AGONISTAS DE RECETOR AT2 SELETIVOS PARA UTILIZAÇÃO NO TRATAMENTO DE CAQUEXIA
- 专利权人:
- STEFAN ANKER;ANDREW COATS
- 发明人:
- JOCHEN SPRINGER,STEFAN ANKER,ANDREW J.S. COATS
- 申请号：
- PT14747861
- 公开号：
- PT3027183T
- 申请日:
- 2014.07.17
- 申请国别(地区):
- PT
- 年份:
- 2019
- 代理人:
- 摘要：
- The present invention is directed to selective AT2 receptor agonist or a pharmaceutically acceptable salt thereof for use in treatment of cachexia, preferably for use in treatment of cancer cachexia.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SELECTIVE AT2 RECEPTOR AGONISTS FOR USE IN TREATMENT OF CACHEXIA
- SELECTIVE AT2 RECEPTOR AGONISTS FOR USING CACKSY TREATMENT
- Agonistes sélectifs du récepteur AT2 destinés à être utilisés dans le traitement de la cachexie
- use of one or more selected from the group consisting of a compound of formula (i), a racemic-diastereomeric mixture and an optical isomer of said compound, and a pharmaceutically acceptable salt and prodrug thereof, method, pharmaceutical composition and treatment kit cachexia and commercial packaging
- Ghrelin receptor agonists for the treatment of cachexia
